Literature DB >> 19196115

Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome.

Ghalib Alkhatib1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19196115      PMCID： PMC6469520          DOI： 10.1089/scd.2008.0304.cp2

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN： 1547-3287            Impact factor:   3.272


× No keyword cloud information.
  20 in total

1.  An HIV-1-infected individual homozygous for the CCR-5 delta32 allele and the SDF-1 3'A allele.

Authors:  H Kuipers; C Workman; W Dyer; A Geczy; J Sullivan; R Oelrichs
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

2.  Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

Authors:  Paul R Gorry; Chengsheng Zhang; Sam Wu; Kevin Kunstman; Elizabeth Trachtenberg; John Phair; Steven Wolinsky; Dana Gabuzda
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

3.  Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

Authors:  R Liu; W A Paxton; S Choe; D Ceradini; S R Martin; R Horuk; M E MacDonald; H Stuhlmann; R A Koup; N R Landau
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

5.  Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

Authors:  S Fais; C Lapenta; S M Santini; M Spada; S Parlato; M Logozzi; P Rizza; F Belardelli
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

Review 7.  HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.

Authors:  Haynes W Sheppard; Connie Celum; Nelson L Michael; Stephen O'Brien; Michael Dean; Mary Carrington; Dale Dondero; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

8.  Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

Authors:  Lokesh Agrawal; Xihua Lu; Jin Qingwen; Zainab VanHorn-Ali; Ioan Vlad Nicolescu; David H McDermott; Philip M Murphy; Ghalib Alkhatib
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

10.  CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.

Authors:  Lokesh Agrawal; Qingwen Jin; Jeff Altenburg; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103
View more
  1 in total

1.  Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Authors:  Paul R Gorry; Fahim Ahmad; Jon Mohl; Ghalib Alkhatib
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.